Methadone has long been a cornerstone of treatment for opioid use disorder, demonstrating its effectiveness as a lifesaving medication. However, it has also been treated as a one-size-fits-all level of care—a role it was never meant to fulfill. When methadone maintenance treatment was first tested in 1964 by Drs. Vincent Dole and Marie Nyswander in […]
addiction medicine
Driving Change with Data: An Inside Look at IRETA’s Research and Evaluation Efforts
Piper Lincoln is the Senior Research Associate at IRETA. Piper plays a crucial role, handling all aspects of research and evaluation. This includes designing data collection methods and analyzing and interpreting results. Her work involves the technical side of data and ensuring that our research and evaluation projects align with best practices. Whether it’s selecting […]
IRETA Continues to Provide Intensive Learning Experience on Substance Use Disorders for Medical and Pharmacy Students
For 23 years, IRETA has hosted medical students for the Scaife Medical Student Fellowship in Substance Use Disorders. The program has been held virtually since 2020, due to COVID-19. This year’s program continued online. For three weeks in both June and July, small cohorts of medical and pharmacy students logged in from across the country […]
The Importance of Speaking the Same Language in Addiction Treatment
There is a recognizable need for improved treatment for substance use disorder in the United States. Drug overdose deaths are at an all-time high and standardization of the delivery and coverage for addiction treatment can be hard to find. Unfortunately, as it stands, addiction treatment and reimbursement practices can vary greatly from state to state, […]
